United Kingdom

OraSure Technologies Inc (OSUR.OQ)

OSUR.OQ on NASDAQ Stock Exchange Global Select Market

15 Dec 2017
Change (% chg)

$0.59 (+3.35%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The... (more)


Beta: 1.42
Market Cap(Mil.): $1,322.97
Shares Outstanding(Mil.): 59.46
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 32.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.01 10.62
ROE: -- 16.85 14.20

BRIEF-Orasure Technologies' unit enters into $143 million deal for supply of Oragene Dx devices‍​

* Says unit has entered into a $143 million deal for the supply of Oragene Dx devices to a consumer genomics customer - SEC filing‍​ Source text for Eikon: Further company coverage:

21 Nov 2017

BRIEF-OraSure Technologies reports Q3 earnings per share $0.09

* OraSure Technologies Inc announces 2017 third quarter financial results

01 Nov 2017

BRIEF-Orasure Q2 earnings per share $0.09

* Q2 earnings per share view $0.07 -- Thomson Reuters I/B/E/S

02 Aug 2017

BRIEF-Orasure's OraQuick HIV Self-Test selected for next phase of STAR Project in Africa

* OraSure Technologies Inc - OraQuick HIV self-test (hivst) has been selected by UnitAid and Population Services International

24 Jul 2017

BRIEF-Orasure Technologies reports agreement with Bill & Melinda Gates Foundation

* Orasure Technologies - announced agreement with Bill & Melinda Gates Foundation,will enable co to offer or a quick HIV self-test at an affordable price

27 Jun 2017

BRIEF-OraSure Tech appoints Mara Aspinall to board of directors

* OraSure Technologies appoints Mara G. Aspinall to board of directors

22 Jun 2017

Earnings vs. Estimates